(Q73384958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Prognostic Factors for Children With Hodgkin’s Disease Treated With Combined-Modality Therapy (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

1 January 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

1 January 2024

3

Melissa M Hudson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

9

Nancy J Tarbell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

8

Karen J Marcus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Qing Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Larry Kun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Howard Weinstein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Amy Billett

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Ron S. Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743158

1 January 2024

Michael P. Link

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743158

1 January 2024

Sarah S. Donaldson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743158

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

15 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743158

full work available at URL

1 January 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.07.124

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Journal of Clinical Oncology

1 January 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

2026-2033

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease

3 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience

1 January 2024

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years

1 January 2024

3

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Treatment of Hodgkin's disease in children with or without radiotherapy

1 January 2024

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French Society of Pediatric Oncology (SFOP) and Hôpital Saint-Louis, Paris

1 January 2024

5

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Pediatric stage IV Hodgkin disease. Long-term survival

1 January 2024

6

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

The intergroup Hodgkin's disease in children. A study of stages I and II.

1 January 2024

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease

1 January 2024

9

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial

1 January 2024

10

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity

1 January 2024

11

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology

1 January 2024

13

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina

1 January 2024

14

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group

1 January 2024

15

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.

1 January 2024

16

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study

1 January 2024

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study

1 January 2024

18

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group

1 January 2024

19

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90

1 January 2024

20

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 January 2024

21

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy

1 January 2024

22

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party

1 January 2024

23

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres

1 January 2024

24

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy

1 January 2024

26

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure

1 January 2024

28

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Nonparametric Estimation from Incomplete Observations

1 January 2024

31

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Regression Models and Life-Tables (with discussion)

1 January 2024

33

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Pathology of Hodgkin's disease.

1 January 2024

34

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival

1 January 2024

37

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.07.124

1 January 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12743158%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference